Replay Revenue and Competitors
Estimated Revenue & Valuation
- Replay's estimated annual revenue is currently $10.5M per year.
- Replay's estimated revenue per employee is $155,000
Employee Data
- Replay has 68 Employees.
- Replay grew their employee count by 5% last year.
Replay's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Portfolio and Program Management | Reveal Email/Phone |
2 | Senior Director Finance | Reveal Email/Phone |
3 | Lab Manager | Reveal Email/Phone |
4 | Principal Data Scientist | Reveal Email/Phone |
5 | Executive Assistant | Reveal Email/Phone |
6 | Principal Scientist | Reveal Email/Phone |
Replay Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is Replay?
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA. The Company has assembled a toolkit of disruptive platform technologies – including a high payload capacity HSV platform, a hypoimmunogenic platform, and a genome writing platform – to address the scientific challenges currently limiting clinical progress and preventing genomic medicine from realising its full potential. The Company’s hub-and-spoke business model separates technology development within Replay from therapeutic development in product companies, which leverage the technology platforms. For example, Replay’s synHSV™ technology, a high payload capacity HSV vector capable of delivering up to 30 times the payload of AAV, is utilized by Replay’s four gene therapy product companies, bringing big DNA treatments to diseases affecting the skin, eye, brain, and muscle. The Company has, additionally, established an enzyme writing product company engaging its evolutionary inference machine learning and genome writing technology to optimize functionality. Replay is led by a world-class team of academics, entrepreneurs and industry experts.
keywords:N/AN/A
Total Funding
68
Number of Employees
$10.5M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.6M | 68 | 10% | N/A |
#2 | $9.2M | 68 | 10% | N/A |
#3 | $11M | 68 | N/A | N/A |
#4 | $10.2M | 68 | 13% | $261.5M |
#5 | $22.7M | 68 | 5% | N/A |